Methods of eliciting a TLR8-mediated cellular response are disclosed. Such methods include administration of either a TLR8 agonist or a TLR8 antagonist to an IRM-responsive cell so that the IRM compound affects at least one TLR8-mediate cellular signaling pathway. In some cases, the method may provide...http://www.google.es/patents/US20040162309?utm_source=gb-gplus-sharePatente US20040162309 - Methods and compositions related to IRM compounds and toll-like receptor 8
Methods and compositions related to IRM compounds and toll-like receptor 8
Número de solicitud: 10/777,310 Número de publicación: US 2004/0162309 A1 Fecha de presentación: 12 Feb 2004 Patente emitida: US7375180 ( Fecha de emisión 20 May 2008)
